CVR number 43454498
Industry 68.1000 Buying and selling of own real estate

Hemo Ejendomme ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  1.1% 1.1% 1.1% 1.1% 1.1%  
Bankruptcy risk  0.0% 0.0% 0.0% 3.7% 3.1%  
Credit score (0-100)  0 0 0 52 55  
Credit rating  N/A N/A N/A BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 2.9 103  
EBITDA  0.0 0.0 0.0 2.9 103  
EBIT  0.0 0.0 0.0 -3.5 89.8  
Pre-tax profit (PTP)  0.0 0.0 0.0 -71.9 4.6  
Net earnings  0.0 0.0 0.0 -56.1 -0.7  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 -71.9 4.6  
 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Tangible assets total  0.0 0.0 0.0 1,539 1,526  
Shareholders equity total  0.0 0.0 0.0 -16.1 -16.8  
Interest-bearing liabilities  0.0 0.0 0.0 1,904 3,895  
Balance sheet total (assets)  0.0 0.0 0.0 2,096 1,973  
Net Debt  0.0 0.0 0.0 1,363 3,533  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 2.9 103  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 3,446.4%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 2,096 1,973  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% -5.8%  
Added value  0.0 0.0 0.0 -3.5 102.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 1,532 -26  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 -1.0 1.0  

Profitability 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% -122.5% 87.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% -0.2% 4.4%  
ROI %  0.0% 0.0% 0.0% -0.2% 4.6%  
ROE %  0.0% 0.0% 0.0% -2.7% -0.0%  

Solidity 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Equity ratio %  0.0% 0.0% 0.0% -0.8% -0.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% 47,091.1% 3,440.9%  
Gearing %  0.0% 0.0% 0.0% -11,817.0% -23,191.4%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 7.2% 3.0%  

Liquidity 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Quick Ratio  0.0 0.0 0.0 2.8 0.2  
Current Ratio  0.0 0.0 0.0 2.7 0.2  
Cash and cash equivalent  0.0 0.0 0.0 541.1 361.8  

Capital use efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 349.5 -1,457.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0